dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Papageorghiou, Aris T. |
dc.contributor.author | Deruelle, Philippe |
dc.contributor.author | Gunier, Robert B. |
dc.contributor.author | Rauch, Stephen |
dc.contributor.author | García-May, Perla K. |
dc.contributor.author | Mhatre, Mohak |
dc.contributor.author | Maiz Elizaran, Nerea |
dc.date.accessioned | 2022-02-25T13:27:20Z |
dc.date.available | 2022-02-25T13:27:20Z |
dc.date.issued | 2021-09 |
dc.identifier.citation | Papageorghiou AT, Deruelle P, Gunier RB, Rauch S, García-May PK, Mhatre M, et al. Preeclampsia and COVID-19: results from the INTERCOVID prospective longitudinal study. Am J Obstet Gynecol. 2021 Sep;225(3):289.e1-289.e17. |
dc.identifier.issn | 0002-9378 |
dc.identifier.uri | https://hdl.handle.net/11351/7087 |
dc.description | Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Hipertensió gestacional; Preeclampsia |
dc.description.sponsorship | The study was supported by the COVID-19 Research Response Fund from the University of Oxford (Ref 0009083). A.T.P. is supported by the Oxford Partnership Comprehensive Biomedical Research Centre with funding from the National Institute for Health Research (NIHR) Biomedical Research Centre funding scheme. The funding organization had no involvement in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript, and decision to submit the manuscript for publication. |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | American Journal of Obstetrics and Gynecology;225(3) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Preeclàmpsia - Epidemiologia |
dc.subject | COVID-19 (Malaltia) - Complicacions |
dc.subject.mesh | Pre-Eclampsia |
dc.subject.mesh | /virology |
dc.subject.mesh | Coronavirus Infections |
dc.subject.mesh | /complications |
dc.title | Preeclampsia and COVID-19: results from the INTERCOVID prospective longitudinal study |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/j.ajog.2021.05.014 |
dc.subject.decs | preeclampsia |
dc.subject.decs | /virología |
dc.subject.decs | infecciones por Coronavirus |
dc.subject.decs | /complicaciones |
dc.relation.publishversion | https://doi.org/10.1016/j.ajog.2021.05.014 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Papageorghiou AT] Nuffield Department of Women’s & Reproductive Health, University of Oxford, Women’s Centre, John Radcliffe Hospital, Oxford, United Kingdom. Oxford Maternal and Perinatal Health Institute, Green Templeton College, University of Oxford, Oxford, United Kingdom. Department of Obstetrics and Gynaecology, St George’s University Hospitals NHS Foundation Trust, London, United Kingdom. [Deruelle P] Department of Obstetrics and Gynecology, Hôpitaux Universitaires de Strasbourg, Strasbourg, France. [Gunier RB, Rauch S] Center for Environmental Research and Community Health (CERCH), School of Public Health, University of California, Berkeley, CA. [García-May PK] Hospital Regional Lic. Adolfo López Mateos ISSSTE, Mexico City, Mexico. [Mhatre M] Tufts Medical Center, Boston, MA. [Maiz N] Servei d'Obstetrícia, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 34187688 |
dc.identifier.wos | 000713539800017 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |